The Monocyte-Activation Test |
Request Information |
“With the PyroDetect System we have a verified non animal alternative to replace the rabbit pyrogen test following successful product specific validation and are pleased that we can continue to meet the expectations of our clients by offering a high quality in vitro method capable of detecting both endotoxin and non-endotoxin contamination.” Dr. Joanna Greenhough; R&D Scientist at Wickham Laboratories Ltd |
![]() |
In the past, the rabbit pyrogen test (RPT) and the Limulus Amoebocyte Lysate (LAL) test were the most frequently applied methods in the pharmaceutical, medical devices and cosmetics industries to detect pyrogens. Both methods are limited in the products and range of pyrogens which can be detected. For example, the LAL test can only detect endotoxins. Both also have a high level of animal consumption. To overcome these limitations, the Monocyte- Activation Test (MAT) was introduced into the European Pharmacopoeia (EP) in 2010 (EP chapter 2.6.30).
Using whole human blood (cryoblood or fresh blood), the MAT immitates the innate immune response to a fever reaction caused by pyrogens. It simulates the human fever reaction better than any animal-based pyrogen test.
The MAT provides a high level of reliability due to including both a positive and a negative control. An international validation project coordinated by the European Center for the Validation of Alternative Methods (ECVAM) in 2005 demonstrated the MAT to be highly robust. Several other published studies have shown the robustness and reliability of the MAT’s test performance.
Merck’s PyroDetect System is a Monocyte-Activation Test which uses cryo-preserved human whole blood and generates an interleukin-1ß response when pyrogens are detected. It allows the performance and calculation of the MAT according to the requirements of the European Pharmacopoeia.
Rabbit | LAL | PyroDetect | ||
---|---|---|---|---|
Test principle | Fever reaction in mammal | Defence mechanism | Fever reaction in human | |
Contamination | Gram-negative (LPS) | + | + | + |
Gram-positive (LTA) | + | - | + | |
Yeasts & Molds | + | - | + | |
Virus | +/-1 | - | + | |
Application | Pharmaceuticals | + | + | + |
Biologicals (e.g. gene therapy, recombinant therapeutic proteins) | + | +/-2 | + | |
Medical devices | +3 | +/-3 | + | |
Cell therapeutics (e.g. monoclonale antibody) | - | +/- | + |
(1 Variable pyrogen results, 2 Rabbit test often required,3 Indirect test with solution in pyrogen-free water)
Table 1: Comparison of the Rabbit Test, the LAL test and the PyroDetect System
Apr
25
|
25/04/18 - 26/04/18
IAFP European Symposium on Food SafetyThe Brewery Conference CentreStockholm, Sweden |
Industrial Biomonitoring | Europe | 20180425 | |
May
07
|
07/05/18 - 10/05/18
TIDES: Oligionucleotide and Peptide TherapeuticsHynes Convention CenterBoston, MA, USA |
Industrial Biomonitoring | North America | 20180507 | |
Jul
08
|
Water Purification,Life Science Research,Industrial Biomonitoring | North America | 20180708 |